Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity
Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunol...
Gespeichert in:
Veröffentlicht in: | PloS one 2015-03, Vol.10 (3), p.e0121623 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | e0121623 |
container_title | PloS one |
container_volume | 10 |
creator | Ruan, Xiaosai Sack, David A Zhang, Weiping |
description | Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunologically different colonization factor antigens (CFAs) and two distinct enterotoxins [heat-labile toxin (LT) and heat-stable toxin type Ib (STa or hSTa)]. ETEC strains expressing any one or two CFAs and either toxin cause diarrhea, therefore vaccines inducing broad immunity against a majority of CFAs, if not all, and both toxins are expected to be effective against ETEC. In this study, we applied the multiepitope fusion antigen (MEFA) strategy to construct ETEC antigens and examined antigens for broad anti-CFA and antitoxin immunogenicity. CFA MEFA CFA/I/II/IV [CVI 2014, 21(2):243-9], which carried epitopes of seven CFAs [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most prevalent and virulent ETEC strains, was genetically fused to LT-STa toxoid fusion monomer 3xSTaA14Q-dmLT or 3xSTaN12S-dmLT [IAI 2014, 82(5):1823-32] for CFA/I/II/IV-STaA14Q-dmLT and CFA/I/II/IV-STaN12S-dmLT MEFAs. Mice intraperitoneally immunized with either CFA/I/II/IV-STa-toxoid-dmLT MEFA developed antibodies specific to seven CFAs and both toxins, at levels equivalent or comparable to those induced from co-administration of the CFA/I/II/IV MEFA and toxoid fusion 3xSTaN12S-dmLT. Moreover, induced antibodies showed in vitro adherence inhibition activities against ETEC or E. coli strains expressing these seven CFAs and neutralization activities against both toxins. These results indicated CFA/I/II/IV-STa-toxoid-dmLT MEFA or CFA/I/II/IV MEFA combined with 3xSTaN12S-dmLT induced broadly protective anti-CFA and antitoxin immunity, and suggested their potential application in broadly effective ETEC vaccine development. This MEFA strategy may be generally used in multivalent vaccine development. |
doi_str_mv | 10.1371/journal.pone.0121623 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1666309730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A422370783</galeid><doaj_id>oai_doaj_org_article_123ad930478141aba7ab1098e791c0fe</doaj_id><sourcerecordid>A422370783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-79501f7755b8c6398b2da972458662a4f9c35387b6d41f4777f8ee2437d506b53</originalsourceid><addsrcrecordid>eNp1UsuO0zAUjRCIGQb-AIElJNQu0vqRxMkGqaraoVIRCwpb6yZxWleeuNgOYj6Zv8Bp0mFmgWQpts8jx_feKHpL8IwwTuZH09kW9OxkWjnDhJKMsmfRNSkYjTOK2fNH-6volXNHjFOWZ9nL6IqmOWY5Ta-jP7eylV5VqOmcMq1DpkGAluvFfDPfhPUDfVmtF2hy12mv5El5c5IjF0Hr1V6207Cpg8ib30bVFzD4HCT42HkotexB1aLJtx0M9DOmoVT_sO1u2qtk66U1_V3wDsFWrjpIq6qDAlQZrdBktVstp8hKD0FWWgP1OUocUg9RwmHwHBOqSvn719GLBrSTb8bvTfR9vdotP8fbr7eb5WIbVylNfMyLFJOG8zQt8ypjRV7SGgpOkzSUjkLSFBULZeRlViekSTjnTS4lTRivU5yVKbuJ3g--J22cGLvkBMmyjOGCMxwYm4FRGziKk1V3YO-FASXOF8buBdjQEy0FoQzqguGE5yQhUAKHkuAil7wgFW5k8Po0_q0r72RdhepZ0E9MnyKtOoi9-SVCYEoxDwYfRgNrfnbS-f9E_jiw9hBSheZpf3BGd76fGbFIKGUc85wFYjIQK2ucs7J5iEKw6Of2Yi_6uRXj3AbZu8fPeBBdBpX9BQxp6yk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1666309730</pqid></control><display><type>article</type><title>Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity</title><source>PubMed (Medline)</source><source>PLoS</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><source>EZB Electronic Journals Library</source><creator>Ruan, Xiaosai ; Sack, David A ; Zhang, Weiping</creator><creatorcontrib>Ruan, Xiaosai ; Sack, David A ; Zhang, Weiping</creatorcontrib><description>Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunologically different colonization factor antigens (CFAs) and two distinct enterotoxins [heat-labile toxin (LT) and heat-stable toxin type Ib (STa or hSTa)]. ETEC strains expressing any one or two CFAs and either toxin cause diarrhea, therefore vaccines inducing broad immunity against a majority of CFAs, if not all, and both toxins are expected to be effective against ETEC. In this study, we applied the multiepitope fusion antigen (MEFA) strategy to construct ETEC antigens and examined antigens for broad anti-CFA and antitoxin immunogenicity. CFA MEFA CFA/I/II/IV [CVI 2014, 21(2):243-9], which carried epitopes of seven CFAs [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most prevalent and virulent ETEC strains, was genetically fused to LT-STa toxoid fusion monomer 3xSTaA14Q-dmLT or 3xSTaN12S-dmLT [IAI 2014, 82(5):1823-32] for CFA/I/II/IV-STaA14Q-dmLT and CFA/I/II/IV-STaN12S-dmLT MEFAs. Mice intraperitoneally immunized with either CFA/I/II/IV-STa-toxoid-dmLT MEFA developed antibodies specific to seven CFAs and both toxins, at levels equivalent or comparable to those induced from co-administration of the CFA/I/II/IV MEFA and toxoid fusion 3xSTaN12S-dmLT. Moreover, induced antibodies showed in vitro adherence inhibition activities against ETEC or E. coli strains expressing these seven CFAs and neutralization activities against both toxins. These results indicated CFA/I/II/IV-STa-toxoid-dmLT MEFA or CFA/I/II/IV MEFA combined with 3xSTaN12S-dmLT induced broadly protective anti-CFA and antitoxin immunity, and suggested their potential application in broadly effective ETEC vaccine development. This MEFA strategy may be generally used in multivalent vaccine development.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0121623</identifier><identifier>PMID: 25803825</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adults ; Animals ; Antibodies ; Antibodies, Bacterial - blood ; Antigenic determinants ; Antigenicity ; Antigens ; Antigens, Bacterial - immunology ; Artificial Gene Fusion - methods ; Bacteria ; Bacterial Toxins - genetics ; Bacterial Toxins - toxicity ; Bacterial Vaccines ; Cholera ; Colonization ; Colonization factor ; Consortia ; Developing countries ; Diarrhea ; Drug dosages ; E coli ; Enterotoxigenic Escherichia coli - genetics ; Enterotoxigenic Escherichia coli - metabolism ; Enterotoxins ; Enterotoxins - genetics ; Enterotoxins - toxicity ; Epitopes ; Escherichia coli ; Escherichia coli Proteins - genetics ; Escherichia coli Proteins - toxicity ; Fimbriae Proteins - genetics ; Fimbriae Proteins - immunology ; Genetic research ; Health aspects ; Heat ; Immunity ; Immunization ; Immunogenicity ; Immunoglobulins ; Immunology ; Laboratory animals ; LDCs ; Mice ; Neutralization ; Neutralization Tests ; Strains (organisms) ; Suidae ; Thermal stability ; Toxins ; Vaccine development ; Vaccines ; Veterinary colleges ; Veterinary medicine ; Wildlife conservation</subject><ispartof>PloS one, 2015-03, Vol.10 (3), p.e0121623</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Ruan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Ruan et al 2015 Ruan et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-79501f7755b8c6398b2da972458662a4f9c35387b6d41f4777f8ee2437d506b53</citedby><cites>FETCH-LOGICAL-c524t-79501f7755b8c6398b2da972458662a4f9c35387b6d41f4777f8ee2437d506b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372207/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372207/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25803825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruan, Xiaosai</creatorcontrib><creatorcontrib>Sack, David A</creatorcontrib><creatorcontrib>Zhang, Weiping</creatorcontrib><title>Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunologically different colonization factor antigens (CFAs) and two distinct enterotoxins [heat-labile toxin (LT) and heat-stable toxin type Ib (STa or hSTa)]. ETEC strains expressing any one or two CFAs and either toxin cause diarrhea, therefore vaccines inducing broad immunity against a majority of CFAs, if not all, and both toxins are expected to be effective against ETEC. In this study, we applied the multiepitope fusion antigen (MEFA) strategy to construct ETEC antigens and examined antigens for broad anti-CFA and antitoxin immunogenicity. CFA MEFA CFA/I/II/IV [CVI 2014, 21(2):243-9], which carried epitopes of seven CFAs [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most prevalent and virulent ETEC strains, was genetically fused to LT-STa toxoid fusion monomer 3xSTaA14Q-dmLT or 3xSTaN12S-dmLT [IAI 2014, 82(5):1823-32] for CFA/I/II/IV-STaA14Q-dmLT and CFA/I/II/IV-STaN12S-dmLT MEFAs. Mice intraperitoneally immunized with either CFA/I/II/IV-STa-toxoid-dmLT MEFA developed antibodies specific to seven CFAs and both toxins, at levels equivalent or comparable to those induced from co-administration of the CFA/I/II/IV MEFA and toxoid fusion 3xSTaN12S-dmLT. Moreover, induced antibodies showed in vitro adherence inhibition activities against ETEC or E. coli strains expressing these seven CFAs and neutralization activities against both toxins. These results indicated CFA/I/II/IV-STa-toxoid-dmLT MEFA or CFA/I/II/IV MEFA combined with 3xSTaN12S-dmLT induced broadly protective anti-CFA and antitoxin immunity, and suggested their potential application in broadly effective ETEC vaccine development. This MEFA strategy may be generally used in multivalent vaccine development.</description><subject>Adults</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antigenic determinants</subject><subject>Antigenicity</subject><subject>Antigens</subject><subject>Antigens, Bacterial - immunology</subject><subject>Artificial Gene Fusion - methods</subject><subject>Bacteria</subject><subject>Bacterial Toxins - genetics</subject><subject>Bacterial Toxins - toxicity</subject><subject>Bacterial Vaccines</subject><subject>Cholera</subject><subject>Colonization</subject><subject>Colonization factor</subject><subject>Consortia</subject><subject>Developing countries</subject><subject>Diarrhea</subject><subject>Drug dosages</subject><subject>E coli</subject><subject>Enterotoxigenic Escherichia coli - genetics</subject><subject>Enterotoxigenic Escherichia coli - metabolism</subject><subject>Enterotoxins</subject><subject>Enterotoxins - genetics</subject><subject>Enterotoxins - toxicity</subject><subject>Epitopes</subject><subject>Escherichia coli</subject><subject>Escherichia coli Proteins - genetics</subject><subject>Escherichia coli Proteins - toxicity</subject><subject>Fimbriae Proteins - genetics</subject><subject>Fimbriae Proteins - immunology</subject><subject>Genetic research</subject><subject>Health aspects</subject><subject>Heat</subject><subject>Immunity</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Immunoglobulins</subject><subject>Immunology</subject><subject>Laboratory animals</subject><subject>LDCs</subject><subject>Mice</subject><subject>Neutralization</subject><subject>Neutralization Tests</subject><subject>Strains (organisms)</subject><subject>Suidae</subject><subject>Thermal stability</subject><subject>Toxins</subject><subject>Vaccine development</subject><subject>Vaccines</subject><subject>Veterinary colleges</subject><subject>Veterinary medicine</subject><subject>Wildlife conservation</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNp1UsuO0zAUjRCIGQb-AIElJNQu0vqRxMkGqaraoVIRCwpb6yZxWleeuNgOYj6Zv8Bp0mFmgWQpts8jx_feKHpL8IwwTuZH09kW9OxkWjnDhJKMsmfRNSkYjTOK2fNH-6volXNHjFOWZ9nL6IqmOWY5Ta-jP7eylV5VqOmcMq1DpkGAluvFfDPfhPUDfVmtF2hy12mv5El5c5IjF0Hr1V6207Cpg8ib30bVFzD4HCT42HkotexB1aLJtx0M9DOmoVT_sO1u2qtk66U1_V3wDsFWrjpIq6qDAlQZrdBktVstp8hKD0FWWgP1OUocUg9RwmHwHBOqSvn719GLBrSTb8bvTfR9vdotP8fbr7eb5WIbVylNfMyLFJOG8zQt8ypjRV7SGgpOkzSUjkLSFBULZeRlViekSTjnTS4lTRivU5yVKbuJ3g--J22cGLvkBMmyjOGCMxwYm4FRGziKk1V3YO-FASXOF8buBdjQEy0FoQzqguGE5yQhUAKHkuAil7wgFW5k8Po0_q0r72RdhepZ0E9MnyKtOoi9-SVCYEoxDwYfRgNrfnbS-f9E_jiw9hBSheZpf3BGd76fGbFIKGUc85wFYjIQK2ucs7J5iEKw6Of2Yi_6uRXj3AbZu8fPeBBdBpX9BQxp6yk</recordid><startdate>20150324</startdate><enddate>20150324</enddate><creator>Ruan, Xiaosai</creator><creator>Sack, David A</creator><creator>Zhang, Weiping</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150324</creationdate><title>Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity</title><author>Ruan, Xiaosai ; Sack, David A ; Zhang, Weiping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-79501f7755b8c6398b2da972458662a4f9c35387b6d41f4777f8ee2437d506b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adults</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antigenic determinants</topic><topic>Antigenicity</topic><topic>Antigens</topic><topic>Antigens, Bacterial - immunology</topic><topic>Artificial Gene Fusion - methods</topic><topic>Bacteria</topic><topic>Bacterial Toxins - genetics</topic><topic>Bacterial Toxins - toxicity</topic><topic>Bacterial Vaccines</topic><topic>Cholera</topic><topic>Colonization</topic><topic>Colonization factor</topic><topic>Consortia</topic><topic>Developing countries</topic><topic>Diarrhea</topic><topic>Drug dosages</topic><topic>E coli</topic><topic>Enterotoxigenic Escherichia coli - genetics</topic><topic>Enterotoxigenic Escherichia coli - metabolism</topic><topic>Enterotoxins</topic><topic>Enterotoxins - genetics</topic><topic>Enterotoxins - toxicity</topic><topic>Epitopes</topic><topic>Escherichia coli</topic><topic>Escherichia coli Proteins - genetics</topic><topic>Escherichia coli Proteins - toxicity</topic><topic>Fimbriae Proteins - genetics</topic><topic>Fimbriae Proteins - immunology</topic><topic>Genetic research</topic><topic>Health aspects</topic><topic>Heat</topic><topic>Immunity</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Immunoglobulins</topic><topic>Immunology</topic><topic>Laboratory animals</topic><topic>LDCs</topic><topic>Mice</topic><topic>Neutralization</topic><topic>Neutralization Tests</topic><topic>Strains (organisms)</topic><topic>Suidae</topic><topic>Thermal stability</topic><topic>Toxins</topic><topic>Vaccine development</topic><topic>Vaccines</topic><topic>Veterinary colleges</topic><topic>Veterinary medicine</topic><topic>Wildlife conservation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruan, Xiaosai</creatorcontrib><creatorcontrib>Sack, David A</creatorcontrib><creatorcontrib>Zhang, Weiping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruan, Xiaosai</au><au>Sack, David A</au><au>Zhang, Weiping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-03-24</date><risdate>2015</risdate><volume>10</volume><issue>3</issue><spage>e0121623</spage><pages>e0121623-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunologically different colonization factor antigens (CFAs) and two distinct enterotoxins [heat-labile toxin (LT) and heat-stable toxin type Ib (STa or hSTa)]. ETEC strains expressing any one or two CFAs and either toxin cause diarrhea, therefore vaccines inducing broad immunity against a majority of CFAs, if not all, and both toxins are expected to be effective against ETEC. In this study, we applied the multiepitope fusion antigen (MEFA) strategy to construct ETEC antigens and examined antigens for broad anti-CFA and antitoxin immunogenicity. CFA MEFA CFA/I/II/IV [CVI 2014, 21(2):243-9], which carried epitopes of seven CFAs [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most prevalent and virulent ETEC strains, was genetically fused to LT-STa toxoid fusion monomer 3xSTaA14Q-dmLT or 3xSTaN12S-dmLT [IAI 2014, 82(5):1823-32] for CFA/I/II/IV-STaA14Q-dmLT and CFA/I/II/IV-STaN12S-dmLT MEFAs. Mice intraperitoneally immunized with either CFA/I/II/IV-STa-toxoid-dmLT MEFA developed antibodies specific to seven CFAs and both toxins, at levels equivalent or comparable to those induced from co-administration of the CFA/I/II/IV MEFA and toxoid fusion 3xSTaN12S-dmLT. Moreover, induced antibodies showed in vitro adherence inhibition activities against ETEC or E. coli strains expressing these seven CFAs and neutralization activities against both toxins. These results indicated CFA/I/II/IV-STa-toxoid-dmLT MEFA or CFA/I/II/IV MEFA combined with 3xSTaN12S-dmLT induced broadly protective anti-CFA and antitoxin immunity, and suggested their potential application in broadly effective ETEC vaccine development. This MEFA strategy may be generally used in multivalent vaccine development.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25803825</pmid><doi>10.1371/journal.pone.0121623</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2015-03, Vol.10 (3), p.e0121623 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1666309730 |
source | PubMed (Medline); PLoS; MEDLINE; DOAJ Directory of Open Access Journals; Free Full-Text Journals in Chemistry; EZB Electronic Journals Library |
subjects | Adults Animals Antibodies Antibodies, Bacterial - blood Antigenic determinants Antigenicity Antigens Antigens, Bacterial - immunology Artificial Gene Fusion - methods Bacteria Bacterial Toxins - genetics Bacterial Toxins - toxicity Bacterial Vaccines Cholera Colonization Colonization factor Consortia Developing countries Diarrhea Drug dosages E coli Enterotoxigenic Escherichia coli - genetics Enterotoxigenic Escherichia coli - metabolism Enterotoxins Enterotoxins - genetics Enterotoxins - toxicity Epitopes Escherichia coli Escherichia coli Proteins - genetics Escherichia coli Proteins - toxicity Fimbriae Proteins - genetics Fimbriae Proteins - immunology Genetic research Health aspects Heat Immunity Immunization Immunogenicity Immunoglobulins Immunology Laboratory animals LDCs Mice Neutralization Neutralization Tests Strains (organisms) Suidae Thermal stability Toxins Vaccine development Vaccines Veterinary colleges Veterinary medicine Wildlife conservation |
title | Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20fusions%20of%20a%20CFA/I/II/IV%20MEFA%20(multiepitope%20fusion%20antigen)%20and%20a%20toxoid%20fusion%20of%20heat-stable%20toxin%20(STa)%20and%20heat-labile%20toxin%20(LT)%20of%20enterotoxigenic%20Escherichia%20coli%20(ETEC)%20retain%20broad%20anti-CFA%20and%20antitoxin%20antigenicity&rft.jtitle=PloS%20one&rft.au=Ruan,%20Xiaosai&rft.date=2015-03-24&rft.volume=10&rft.issue=3&rft.spage=e0121623&rft.pages=e0121623-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0121623&rft_dat=%3Cgale_plos_%3EA422370783%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1666309730&rft_id=info:pmid/25803825&rft_galeid=A422370783&rft_doaj_id=oai_doaj_org_article_123ad930478141aba7ab1098e791c0fe&rfr_iscdi=true |